Listonstreetpulse.com announces that the business development team at Amazon.com, the world’s largest on-line retail company, has contacted Arrayit Corporation (OTC: ARYC). Analysts at Amazon have recognized ARYC as an attractive Amazon seller and have offered to build an Arrayit storefront on Amazon. This will help in increasing sales traffic and also help Amazon to offer ARYC’s 1,100 products and services to its customers worldwide.
Arrayit is planning to leverage the extensive Amazon storefront as a supplement to the Arrayit Store and to its network of 55 international distributors. ARYC believes that the Amazon listing will help boost sales, particularly for its life sciences products and diagnostic tests.
ARYC’s Arrayit OvaDx® Pre-Symptomatic Test for Ovarian Cancer and the Arrayit PDx™ Pre-Symptomatic Test for Parkinson’s Disease will be available to the public following FDA approval.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
